Goodwill and Purchased Intangible Assets

12 Months Ended

Jun. 30, 2017

Goodwill and Purchased Intangible Assets

Goodwill and Purchased Intangible Assets

6. Goodwill and Purchased Intangible Assets

Goodwill

Goodwill as of June 30, 2017 and 2016 and changes in the carrying amount of goodwill for the respective periods are as follows (in thousands):

	As of June 30,
	2017			2016
Balance at the beginning of the period	$	57,848		$	58,054
Currency translation		(36	)		(206	)

Balance at the end of the period	$	57,812		$	57,848

In fiscal 2017 the Company performed its annual goodwill impairment test and determined that there was no impairment to goodwill. The Company will continue to monitor its recorded goodwill for indicators of impairment.

Purchased Intangible Assets

The Company's intangible assets associated with completed acquisitions and purchased patent license are as follows (in thousands):

			As of June 30, 2017							As of June 30, 2016
	Useful Lives		Gross Carrying Amount		Accumulated Amortization			Net Amount		Gross Carrying Amount		Accumulated Amortization			Net Amount
	(in years)
Developed technology		5 - 6	$	46,700	$	(46,700	)	$	—	$	46,743	$	(39,132	)	$	7,611
Patent license		7		1,000		(36	)		964		—		—			—

Total intangible assets			$	47,700	$	(46,736	)	$	964	$	46,743	$	(39,132	)	$	7,611

During fiscal year 2017, the Company purchased a patent license with a useful life of seven years. The Company did not identify any triggering events that would indicate potential impairment of its definite-lived intangible and long-lived assets as of June 30, 2017 and 2016.

Amortization expense related to purchased intangible assets was $7.7 million, $8.0 million and $7.9 million for the years ended June 30, 2017, 2016 and 2015, respectively.

The estimated future amortization expense of purchased intangible assets as of June 30, 2017 is as follows (in thousands):

Year Ending June 30,	Amount
2018	$	143
2019		143
2020		143
2021		143
2022		143
Thereafter		249

	$	964

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details